Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Eden vs Levity

Eden
Site position #16

Higher grade

Levity
Site position #406

Lower grade

The verdict

Eden takes it — 81.6/100 to 58.8/100.

Eden grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Eden advertises lower-priced compounded bundles, but its offer and linked membership and warranty terms need to be reconciled before purchase.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEden +54
85
31
Dose & formulationEden +1
86
85
Clinical oversightEven
55
55
Labs & monitoringEden +28
92
64
FulfillmentEden +16
93
77
Contract termsEden +37
90
53
Eden · top barLevity · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricEdenLevity
WeighScore81.6/10058.8/100
GradeB−C
Site position#16#406
SemaglutideAdvertised $99/mo bundle; linked membership terms conflict—confirm checkout$1,199/mo (all doses, bundle, brand-name)
TirzepatideAdvertised $129/mo bundle; linked membership terms conflict—confirm checkout$1,299/mo (all doses, bundle, brand-name)
CoverageAll 50 states36 states
Brand-name accessYesYes
Oral / sublingualNot confirmedNot confirmed
Eden

Site position #16 · B−

FDAWarning letter issued to Eden Health International Inc. dba Eden in June 2026. See the FDA warning-letter database.

Strengths

  • Current compounded offer includes medication and support
  • Homepage also advertises branded prescription pathways; eligibility and cost require confirmation
  • Named pharmacy operation and partner network can be investigated

What to consider

  • Linked membership terms describe a separate fee model
  • Landing-page warranty and terms use different thresholds and conditions
  • FDA warning history remains relevant; a new offer does not establish resolution
Levity

Site position #406 · C

FDAWarning letter issued to Levity Inc. dba Levity in February 2026. See the FDA warning-letter database.

Strengths

  • FDA-approved branded Mounjaro, Wegovy, and Ozempic only
  • All-inclusive fee covers Rx, consult, shipping, and support
  • LegitScript verified with named pharmacy and physician leads
  • Available across 34 states with unlimited clinical support

What to consider

  • Premium pricing, roughly 1,199 to 1,599 per month
  • No compounded lower-cost alternatives
  • Support hours limited to weekday business hours
  • Bundled fee may exceed insurance-covered branded options
  • FDA issued Levity Inc. dba Levity a warning letter in February 2026; the letter is public in FDA's warning-letter database

Featured provider

Eden

Eden scores 81.6/100 (B−). Eden advertises lower-priced compounded bundles, but its offer and linked membership and warranty terms need to be reconciled before purchase.

Commercial relationships affect this placement. The score comparison above is separate.

FDAWarning letter issued to Eden Health International Inc. dba Eden in June 2026. See the FDA warning-letter database.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard